FREDERICK, Md., Nov. 14 /PRNewswire-FirstCall/ -- BioElectronics Corporation, , announced today that Lawrence H. Rosen, CPA has joined the Company as its Chief Financial Officer.
Mr. Rosen is a Certified Public Accountant with extensive experience as a business consultant in financial statement presentation and SEC reporting. He is a former Touche Ross & Co. partner and has been chief financial officer for several start up companies, including a medical device company.
Andrew Whelan, Chief Executive Officer, commented, “We are extremely pleased to have Larry join the Company. He will help complete our SEC registration, making the Company a fully reporting entity which will qualify BioElectronics for OTC-BB listing.”
“Larry’s extensive financial and general management skills will help accelerate our capability and expand our domestic and international growth,” Mr. Whelan concluded.
ActiPatch(TM) is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.
For more information visit http://www.bioelectronicscorp.com
Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
BioElectronics Corporation
CONTACT: Andrew J. Whelan, President & CEO of BioElectronics Corporation,+1-301-644-3906, Fax: +1-301-644-3937, info@bioelectronicscorp.com
Web site: http://www.bioelectronicscorp.com/
